Kyrillus Shohdy, MD Profile
Kyrillus Shohdy, MD

@Kyrillus2

Followers
577
Following
734
Media
16
Statuses
441

Clinical Lecturer in Cancer Sciences @UoGlasgow, Honorary Medical Oncologist @NHSGGC, ex-Fellow @TheChristieNHS, @ASCO-LIFe Fellow @WeillCornell.

Glasgow
Joined July 2017
Don't wanna be here? Send us removal request.
@ScienceMagazine
Science Magazine
2 months
A previously unrecognized estrogen-dependent signaling pathway in the gut regulates visceral pain sensitivity in mice, according to a new Science study. The findings provide a pathway toward targeted therapeutic strategies. 📄: https://t.co/KANGJGjCt4 #SciencePerspective:
4
90
339
@Aiims1742
Anirban Maitra
2 months
Cancer cell plasticity and resistance to KRAS inhibition Two recent preclinical examples in #ColorectalCancer @CD_AACR https://t.co/ydxGI93QMe @Cancer_Cell https://t.co/DG7HXUlipn
2
30
125
@ArndtVogel
Arndt Vogel
3 months
🔥off the press🔥 Cholangiocarcinoma 2026: status quo, unmet needs and priorities @NatRevGastroHep https://t.co/bG6kCL3DSU 👉get the lastest, most comprehensive summary on cholangiocarcinoma 👏fantastic team effort! @myESMO @EASLedu @ILCAnews
1
70
221
@CancerGrand
Cancer Grand Challenges
3 months
How can a gene mutation be present throughout the body yet cause cancer only in certain tissues? This is exactly the challenge our SPECIFICANCER team took on 7 years ago. Read the newly published impact report from the team that reshaped our understanding of tissue specificity
1
8
28
@GaiaGriguolo
Gaia Griguolo
3 months
Systemic review on neurocognitive outcomes in patients with🧠 metastases in @TheLancetOncol Urgent need for research assessing modality-specific neurocognitive tox and optimal sequencing of therapies! @OncoAlert #brainmets https://t.co/4ZocYIuxmi
Tweet card summary image
thelancet.com
Multimodality therapy, including surgery, radiotherapy, and systemic therapy, has significantly improved overall survival for patients with brain metastases. However, treatment-related neurocognitive...
2
9
23
@Aiims1742
Anirban Maitra
3 months
What’s true in #PancreaticCancer precursor lesions is also true in #ColorectalCancer precursor lesions. @cncurtis @SnyderShot @StanfordMed demonstrate polyclonal origin of adenomas in patients with FAP. Cancer as a manifestation of convergent evolution! https://t.co/Bnqko2Z2Y8
2
60
209
@Kyrillus2
Kyrillus Shohdy, MD
3 months
Groundbreaking work just came today from  @owen_sansom Lab, spearheaded by Mark White and exceptionally talented team @CRUKScotland & @UoFGlasgow The work unmasked MAPK-driven Colorectal Cancer's clever escape from therapy. Yes Always search for the WNT.  https://t.co/MjJErUh8Yz
0
3
4
@AlexRavenBio
Alex Raven
3 months
Very proud of all our hardwork! Exciting new paper exploring the origin of liver cancer https://t.co/bmmXgNlzFI @owen_sansom
Tweet card summary image
nature.com
Nature - Zonal positioning in the liver determines whether the CTNNB1 oncogene can induce liver cancer.
1
22
91
@DaisukeKotani
Daisuke Kotani, MD, Ph.D 小谷 大輔
3 months
Paneth-like transition drives resistance to dual targeting of KRAS & EGFR in CRC ✅CRC cells surviving combined KRAS & EGFR inhibition acquire Paneth-like state ✅SMAD1-FGFR3 axis triggers Paneth-like plasticity ✅FGFR3 blockade could overcome plasticity-driven drug tolerance
Tweet card summary image
cell.com
Zhang et al. show that CRC cells adopt a Paneth-like state to evade dual KRAS and EGFR inhibition. They identify a SMAD1-FGFR3 axis that drives lineage plasticity and MAPK reactivation, conferring...
0
12
47
@Aiims1742
Anirban Maitra
4 months
Provocative new data in @NatureMedicine from @JenWargoMD @nadim_ajami & colleagues @MDAndersonNews Microbial signals in primary and metastatic brain tumors https://t.co/6htdGy7vPt Orthogonal validation using multiple platforms provides support for this observation
0
16
65
@Erman_Akkus
Erman Akkus
4 months
📌Inaccurate lymph node clinical staging in early and intermediate-risk rectal cancer @EORTC 🚨19.5% understaged and 62.4% overstaged ✅Seems no survival effect ➡️At least a destressing data when MRI shows 1-3 small lymph nodes that we can not decide whether pathologic or not
4
18
41
@yuzaR___
Yury Zablotski
4 months
ANOVA in R! 💪 in ONE LINE OF CODE! ggstatsplot::ggbetweenstats(ISLR::Wage, race, wage) Watch the video for more details: https://t.co/pvjcai0see #rstats #statistics #dataanalysis #stats #datascience #r4ds
4
84
507
@DrRishabhOnco
Dr Rishabh Jain
6 months
🍽️ Turning “no appetite” into “pass the plate” with olanzapine 📝 JNCCN 2025 | OlAnCa trial | DB RCT | n=164 | Cairo Univ 🔑 Trial essentials • 🌐 Incurable solid tumors + cachexia • 🎲 Randomized: Olanzapine 5 mg QHS vs placebo • 🎯 Primary: Appetite (ESAS-Anorexia) @ 1 wk
4
31
116
@Carol2Path
Carol N. Rizkalla, MD
7 months
#USCAP2025 w/ Dr Voltaggio Esophageal ⬆️ grade dysplasia/intramucosal adeno → treated with EMR. Presence of muscularis mucosa = lateral margin; large vessels + loose CT = deep margin. Recommendation to pin specimen before fixing for easier margin assessment. #PathWebinarPearls
2
39
92
@JCellBiol
Journal of Cell Biology
6 months
New review: Mellor, Larson, and @DrMengWang discuss the molecular mechanisms of mammalian genomic instability arising from folate deficiency and how this impacts genome biology in health and disease. https://t.co/drz4rp0yqn #CellMetabolism
0
5
7
@oncodaily
OncoDaily
7 months
New Paper Alert: BRCA1/2 Mutations and RB1 Alterations Predict Poorer Outcomes With Endocrine Therapy ± CDK4/6 Inhibitors in HR+/HER2– Breast Cancer Authors: Hamdy A. Azim, Hagar Elghazawy (@HagarElghazawy1), Kyrillus S. Shohdy (@Kyrillus2 ) Shaimaa Lasheen, Mahmoud Elghazawy,
1
1
6
@NiuSanford
Dr. Nina Niu Sanford
7 months
Here is a video on management of 4 common lower GI radiotherapy toxicities: 1. Radiation dermatitis 2. Diarrhea 3. Acute RT proctitis 4. Late/chronic RT proctitis Hope it is helpful! Full video (16 min) & slides 🧵 thread below. 1/X
9
86
308
@RyanNipp
Ryan Nipp, MD, MPH, MBA, FASCO
7 months
Olanzapine for Anorexia in Patients With Incurable #Cancer and #Cachexia (OlAnCa): A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. https://t.co/0rOzyCvthm @JNCCN @CancerCachexia #CancerResearch #PallOnc #SuppOnc #CancerCare
2
40
105
@Kyrillus2
Kyrillus Shohdy, MD
7 months
Our study is out @ESMO_Open. The largest cohort from Northern African background on BRCA1/2 genetics. So pleased to lead such work that bridges the equity gap in precision oncology.
@ESMO_Open
ESMO Open
7 months
Genetic testing for BRCA1/2 variants in Northern African women with ovarian and breast cancers: a multicentre study of an under-represented ancestry in @ESMO_Open. Unique BRCA1/2 variation patterns; 45/85 VUS, affecting 60% of pts, were reclassified. https://t.co/KgWJzjQ9vG
1
0
5
@CRUK_SI
CRUK Scotland Inst
7 months
We are recruiting a Senior Scientific Officer to work with @NadiaNasreddin in @owen_sansom's lab on the project WNT-driven cell competition: a target for novel preventative strategies against colorectal adenoma formation 📅Closing date: 15 August 2025 🔗 https://t.co/tED9IHS8SP
0
6
11